Akut limfoid leukémia (ALL): vizsgálatok itt: Franciaország
39 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 2/3. fázisTaking peopleA Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
- Where
- Paris, Pessac
- Életkor
- 12 év and over
- People
- 340 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT07570173 · EU 2025-522267-15-00 - 4. fázisTaking peopleAsciminib Roll-over Study
- Where
- Bordeaux, Caen Cedex 9, Clermont-Ferrand, Lille, Lyon, Marseille, Nantes Cedex 1, Nice, Paris, Poitiers, Strasbourg Cedex 2, Toulouse, Vandoeuvre Les Nancy
- Életkor
- 7 év to 100 év
- People
- 347 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT04877522 · EU 2023-507557-16-00 - 1/2. fázisTaking peopleSubstudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Where
- Bordeaux, Lyon, Marseille, Nantes, Villejuif
- Életkor
- 6 hónap to 25 év
- People
- 90 worldwide
- Run by
- Merck Sharp & Dohme LLC
See details and how to joinNCT06395103 · EU 2023-507178-41-00 - 3. fázisTaking peopleInternational Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
- Where
- Amiens, ANGERS Cedex 09, Besancon Cedex, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, Grenoble cedex 09, Lille, Limoges, Lyon, Marseille, Montpellier Cedex 05, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen, Saint-Etienne, Strasbourg Cedex 2, Toulouse, Tours, Vanoeuvre les Nancy
- Életkor
- 1 év to 64 év
- People
- 750 worldwide
- Run by
- Charite University, Berlin, Germany
See details and how to joinNCT07476729 · EU 2023-509392-17-00 - 2/3. fázisTaking peopleFramework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALL
- Where
- Paris
- Életkor
- 3 hónap to 25 év
- People
- 1000 worldwide
- Run by
- Bambino Gesù Hospital and Research Institute
See details and how to joinNCT07297914 · EU 2025-522052-13-00 - 3. fázisTaking peopleInterfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
- Where
- Amiens Cedex 1, Besancon Cedex, Bordeaux, Grenoble Cedex 9, Lille Cedex, Lyon, Marseille, Montpellier, Nantes, Nice, Paris, Poitiers, Reims, Rennes, Rouen Cedex, St Etienne Cedex 2, Strasbourg Cedex 2, Toulouse Cedex 9, Vandoeuvre Les Nancy
- Életkor
- 1 nap to 1 év
- People
- 160 worldwide
- Run by
- Princess Maxima Center for Pediatric Oncology
See details and how to joinNCT05327894 · EU 2022-502503-30-00 - 3. fázisTaking peopleSingle-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
- Where
- Angers, La Roche-sur-Yon, Nantes, Rennes, Rouen
- Életkor
- 18 év and over
- People
- 63 worldwide
- Run by
- CSL Behring
See details and how to joinNCT07648264 · EU 2026-525626-38-00 - 1/2. fázisTaking peopleAZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
- Where
- Caen, Marseille, Nantes, Paris, Pierre-Bénite, Toulouse Cedex 9
- Életkor
- 12 év and over
- People
- 255 worldwide
- Run by
- AstraZeneca
See details and how to joinNCT06137118 · EU 2023-505840-20-00 - 1/2. fázisTaking peopleSafety and Efficacy of Ponatinib for Treatment of Pediatric Recurrent or Refractory Leukemias, Lymphomas or Solid Tumors
- Where
- Paris, Poitiers, Rennes
- Életkor
- 1 év to 17 év
- People
- 70 worldwide
- Run by
- Incyte Biosciences International Sàrl
See details and how to joinNCT03934372 · EU 2023-509699-41-00 - 1/2. fázisTaking peopleA Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
- Where
- Paris, Pessac, Pierre-Bénite, Villejuif
- Életkor
- 30 nap and over
- People
- 447 worldwide
- Run by
- Syndax Pharmaceuticals
See details and how to joinNCT04065399 · EU 2024-513759-34-00 - 1/2. fázisNot yet taking people in FranciaországStudy of the safety and efficacy of asciminib in pediatric and young adult participants with r/r Ph+ or ABL-class Ph-like ALL
- Where
- Bordeaux, Lyon, Marseille, Nantes, Paris, Pessac, Rennes Cedex 9
- Életkor
- Up to 64 év
- People
- 22 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-522019-40-00 · EU 2025-522019-40-00 - 2. fázisTaking peopleA Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
- Where
- Bordeaux, Lille, Lyon, Montpellier, Nantes, Nice, Paris, Rennes, Strasbourg Cedex 2, Toulouse Cedex 9, Vandoeuvre lès Nancy
- Életkor
- 1 év to 17 év
- People
- 100 worldwide
- Run by
- Pfizer
See details and how to joinNCT05748171 · EU 2023-509810-13-00 - 2. fázisTaking peopleFaecal Microbiota Transplantation After Allogeneic Stem Cell Transplantation
- Where
- Amiens, Angers, Besançon, Clermont-Ferrand, Grenoble, Lille, Limoges, Lyon, Nancy, Nantes, Nice, Paris, Pessac, Poitiers, Rouen, Saint-Etienne, Toulouse
- Életkor
- 18 év and over
- People
- 150
- Run by
- University Hospital, Clermont-Ferrand
See details and how to joinNCT04935684 - 2/3. fázisTaking peopleAllogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
- Where
- Bordeaux, Clermont-Ferrand, La Tronche, Lille Cedex, Lyon, Marseille, Montpellier Cedex 5, Nantes, Paris, Rennes, Rouen Cedex, Strasbourg Cedex 2, Vandoeuvre Les Nancy Cedex
- Életkor
- 1 hónap to 18 év
- People
- 1800 worldwide
- Run by
- St. Anna Kinderkrebsforschung
See details and how to joinNCT01949129 · EU 2024-512657-24-00 - No phaseTaking peopleStudy of Cell-free DNA in Children and Adolescents With Acute Lymphoblastic Leukemia
- Where
- Paris
- Életkor
- Up to 18 év
- People
- 205
- Run by
- Assistance Publique - Hôpitaux de Paris
See details and how to joinNCT07483476 - 3. fázisTaking peopleA Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia
- Where
- Amiens Cedex 1, Angers, Besancon Cedex, Bordeaux, Brest, Caen Cedex 9, Clermont-Ferrand, Dijon, La Tronche, Lille Cedex, Limoges, Lyon Cedex 02, Marseille, Montpellier Cedex 5, Nantes, Nice, Paris, Poitiers, Reims Cedex, Rennes, Rouen Cedex, Saint-Denis, Saint-Priest-en-Jarez, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy
- Életkor
- 0 év to 45 év
- People
- 6430 worldwide
- Run by
- Mats Heyman
See details and how to joinNCT04307576 · EU 2022-501050-11-01 - No phaseTaking peopleEWALL-PH OBSERVARTORY 2022
- Where
- Amiens, Angers, Bayonne, Bordeaux, Clamart, Clermont-Ferrand, Corbeil-Essonnes, Grenoble, La Réunion, Le Chesnay, Le Mans, Lille, Marseille, Nancy, Nice, Paris, Pierre-Bénite, Saint-Etienne, Strasbourg, Toulouse
- Életkor
- 18 év and over
- People
- 100
- Run by
- Versailles Hospital
See details and how to joinNCT07684131 - No phaseNot yet taking people in FranciaországStudy of NK Cells in the Monitoring of Patients With Acute Leukemia or Myelodysplasia
- Where
- Nantes
- Életkor
- 18 év and over
- People
- 55
- Run by
- Nantes University Hospital
See details and how to joinNCT07249476 - No phaseTaking peopleCollection of Biological Samples From Patients Treated With CAR-T Cells for Hematological Malignancies
- Where
- Montpellier
- Életkor
- 18 év and over
- People
- 300
- Run by
- University Hospital, Montpellier
See details and how to joinNCT04290000 - 2. fázisNot yet taking people in FranciaországA PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APPROACH. ALL-TARGET TRIAL
- Where
- Aix En Provence, Amiens Cedex 1, Angers, Argenteuil Cedex, Avignon, Bayonne, Besancon Cedex, Bobigny, Brest, Caen, Castelnauv Le Lez, Clamart, Clermont-Ferrand, Corbeil Essonnes Cedex, Creteil, Dijon, Dunkirk Cedex 1, Epagny Metz-tessy, Grenoble Cedex 09, Le Chesnay Rocquencourt, Lille Cedex, Limoges Cedex 1, Marseille, Metz Cedex 03, Montpellier Cedex 5, Mulhouse, Nantes, Nice, Nîmes, Orleans Cedex 2, Paris, Paris Cedex 12, Paris Cedex 13, Perpignan Cedex, Pessac, Pierre-Bénite, Poitiers, Reims Cedex, Rennes, Roubaix, Rouen, Saint-Priest-en-Jarez, Toulouse Cedex 9, Tours Cedex 9, Vandoeuvre Les Nancy, Villejuif
- People
- 86 worldwide
- Run by
- Centre Hospitalier De Versailles
See details and how to join2024-516570-30-00 · EU 2024-516570-30-00 - 1/2. fázisTaking peopleInotuzumab ozogamicin for Acute Lymphoblastic Leukemia
- Where
- Lille Cedex, Lyon, Nantes, Nice, Paris, Toulouse Cedex 9
- Életkor
- Up to 17 év
- People
- 142 worldwide
- Run by
- Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)
See details and how to join2023-504694-20-00 · EU 2023-504694-20-00 - No phaseTaking peopleCreation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelodysplastic Syndrome (MDS) Monitored at the Nantes University Hospital
- Where
- Nantes
- Életkor
- 18 év and over
- People
- 1000
- Run by
- Nantes University Hospital
See details and how to joinNCT06681363 - 3. fázisTaking peopleStudy on chemotherapy and experimental drugs in patients with Philadelphia Chromosome positive and ABL-class Philadelphia Chromosome-Like B-cell Acute Lymphoblastic Leukemia
- Where
- Amiens Cedex 1, Angers, Besançon Cedex, Bordeaux, Brest, Caen, Clermont-Ferrand, Dijon, La Tronche, Lille Cedex, Limoges, Lyon, Marseille, Montpellier Cedex 5, Nantes, Nice, Paris, Reims Cedex, Rennes, Rouen Cedex, St Etienne Cedex 2, Strasbourg Cedex 2, Toulouse Cedex 9, Tours, Vandoeuvre Les Nancy
- Életkor
- Up to 64 év
- People
- 87 worldwide
- Run by
- Universita Degli Studi Di Milano Bicocca
See details and how to join2025-520982-39-00 · EU 2025-520982-39-00 - 3. fázisTaking peopleA Study of Olverembatinib in Patients With Newly Diagnosed Ph+ ALL (POLARIS-1)
- Where
- Bobigny Cedex, Le Chesnay Rocquencourt, Lyon, Nantes, Nice, Pessac, Pierre-Bénite, Poitiers, Toulouse Cedex 9
- Életkor
- 18 év and over
- People
- 350 worldwide
- Run by
- Ascentage Pharma Group Inc.
See details and how to joinNCT06051409 · EU 2024-511496-14-00 - No phaseNot yet taking people in FranciaországRole of T Lymphocytes in Hypersensitivity Reactions to Asparaginase in Patients Treated for Acute Lymphoblastic Leukemia.
- Where
- Marseille, Nice
- Életkor
- 1 év to 99 év
- People
- 20
- Run by
- Centre Hospitalier Universitaire de Nice
See details and how to joinNCT07529223